Intranasal Drug Delivery: Potential Advantages and Limitations from a Clinical Pharmacokinetic Perspective

Antonio E. Pontiroli, Anna Calderara, Guido Pozza

Research output: Contribution to journal › Article

Cite this

@article{83a9b0f14ed3407e982e6579e3c67c69,

title = "Intranasal Drug Delivery: Potential Advantages and Limitations from a Clinical Pharmacokinetic Perspective",

author = "Pontiroli, {Antonio E.} and Anna Calderara and Guido Pozza",

year = "1989",

doi = "10.2165/00003088-198917050-00001",

language = "English",

volume = "17",

pages = "299--307",

journal = "Clinical Pharmacokinetics",

issn = "0312-5963",

publisher = "Adis International Ltd",

number = "5",

}

TY - JOUR

T1 - Intranasal Drug Delivery

T2 - Potential Advantages and Limitations from a Clinical Pharmacokinetic Perspective

AU - Pontiroli, Antonio E.

AU - Calderara, Anna

AU - Pozza, Guido

PY - 1989

Y1 - 1989

UR - http://www.scopus.com/inward/record.url?scp=0024443171&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024443171&partnerID=8YFLogxK

U2 - 10.2165/00003088-198917050-00001

DO - 10.2165/00003088-198917050-00001

M3 - Article

C2 - 2510960

AN - SCOPUS:0024443171

VL - 17

SP - 299

EP - 307

JO - Clinical Pharmacokinetics

JF - Clinical Pharmacokinetics

SN - 0312-5963

IS - 5

ER -